Evaluation of the efficacy of Denosumab in adult patients with Langerhans Cell Histiocytosis (LCH) : a multiple-site, single arm, open label Clinical Trial.
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2017
At a glance
- Drugs Denosumab (Primary)
- Indications Langerhans cell histiocytosis
- Focus Therapeutic Use
- 09 Jun 2017 New trial record